Compare MXCT & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | VIOT |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.2M | 109.1M |
| IPO Year | 2021 | 2018 |
| Metric | MXCT | VIOT |
|---|---|---|
| Price | $1.45 | $1.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.11 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 420.9K |
| Earning Date | 11-10-2026 | 08-27-2026 |
| Dividend Yield | N/A | ★ 5.00% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,026,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.53 | $4.78 |
| P/E Ratio | ★ N/A | $3.56 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $0.66 |
| 52 Week High | $1.81 | $3.61 |
| Indicator | MXCT | VIOT |
|---|---|---|
| Relative Strength Index (RSI) | 69.59 | 47.62 |
| Support Level | $1.15 | $1.20 |
| Resistance Level | $1.54 | $1.50 |
| Average True Range (ATR) | 0.07 | 0.11 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 85.69 | 18.09 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Viomi Technology Co Ltd, along with its subsidiaries, specializes in the development and sale of Internet-of-Things-enabled smart home products, particularly focusing on home water solutions. The company markets its products in China and generates the majority of its revenue through the sale of smart water purification systems and other connected home devices designed to improve convenience and automation in residential settings. Its product offerings include water purification products, water heaters, smart water kettles, electric kettles, water filters, range hoods, gas stoves, and other small appliances.